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Polycomb repressive complex 2 (PRC2) regulates
gene expression during lineage specification through
trimethylation of lysine 27 on histoneH3 (H3K27me3).
In Drosophila, polycomb binding sites are dynamic
chromatin regions enriched with the histone variant
H3.3. Here, we show that, in mouse embryonic
stem cells (ESCs), H3.3 is required for proper estab-
lishment of H3K27me3 at the promoters of develop-
mentally regulated genes. Upon H3.3 depletion,
these promoters show reduced nucleosome turn-
over measured by deposition of de novo synthesized
histones and reduced PRC2 occupancy. Further, we
show H3.3-dependent interaction of PRC2 with the
histone chaperone, Hira, and that Hira localization
to chromatin requires H3.3. Our data demonstrate
the importance of H3.3 in maintaining a chromatin
landscape in ESCs that is important for proper
gene regulation during differentiation. Moreover,
our findings support the emerging notion that H3.3
has multiple functions in distinct genomic loca-
tions that are not always correlated with an ‘‘active’’
chromatin state.
INTRODUCTION
Chromatin in embryonic stem cells (ESCs) is characterized by an
open state thought to allow for rapid transcription changes that
accompany the transition from pluripotency to differentiated
cell states (Gaspar-Maia et al., 2011; Meshorer et al., 2006).
ESC chromatin displays an overall less condensed structure
with relative absence of constitutive heterochromatin andgenome-wide low-level transcriptional activity. The chromatin
landscape of ESCs reflects this genome activity, displaying
abundant levels of histone posttranslational modifications asso-
ciated with active transcription, such as trimethylation of lysine 4
on histone H3 (H3K4me3) and acetylation of histones H3 and H4.
Actively transcribed regions of metazoan genomes are also
enriched with the histone H3 variant H3.3. H3.3 contains only
four to five amino acid changes from canonical H3 isoforms
H3.1 and H3.2 (Figure S1A available online), yet it displays
distinct properties in regulation and timing of expression and
mode of incorporation into chromatin (Filipescu et al., 2013).
Whereas canonical H3 is expressed only during S phase,
showing replication-dependent incorporation by its chaperone,
CAF-1, H3.3 is expressed throughout the cell cycle and shows
distinct patterns of genomic enrichment mediated by at least
two independent chaperone systems, with Hira mainly facili-
tating genic deposition and Atrx/Daxx responsible for repeat
regions. Although H3.3 deposition has long been associated
with gene activation, surprisingly, our recent genome-wide
profiling demonstrated that H3.3 is also enriched at the pro-
moters of developmentally regulated genes in ESCs (Goldberg
et al., 2010), which are typically silenced or transcribed at low
levels in ESCs.
Promoters of developmentally regulated genes in ESCs
are defined by the presence of both activation-associated
H3K4me3 and repression-associated H3K27me3. These dually
modified regions, dubbed ‘‘bivalent domains’’ (Bernstein et al.,
2006), are proposed to be poised for activation upon differentia-
tion. Promoters of bivalent genes are bound by RNA polymerase
II phosphorylated on serine 5 (RNAPII S5p) associated with tran-
scriptional initiation and recruitment of the H3K4 methyltransfer-
ase (Brookes and Pombo, 2009; Weake and Workman, 2010).
These promoters are also bound by polycomb repressive com-
plex 2 (PRC2), which contains the enzymatic activity responsible
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Reinberg, 2011). In Drosophila, H3.3 is enriched at polycomb
response elements (PREs), regions of PRC2 binding associated
with highly dynamic chromatin (Mito et al., 2007). That, coupled
with our own finding that H3.3 localizes to developmental
promoters in ESCs that are not highly transcriptionally active,
suggests that H3.3 may have a role at lowly transcribed genes.
Here, we show that H3.3 promotes establishment of the biva-
lent chromatin landscape in ESCs, with H3.3 depletion leading to
reduced levels of H3K27me3 enrichment at the promoters of
developmentally regulated genes, altered ESC developmental
potential, and misregulation of bivalent genes upon differentia-
tion. Our data suggest that, rather than acting as a preferred sub-
strate for PRC2 activity, H3.3 facilitates a dynamic chromatin
environment that allows for optimal PRC2 binding and activity.
Our studies underscore the intriguing possibility that chromatin
dynamics themselves play an important role in the establishment
of chromatin landscapes, with subsequent effects on differenti-
ation and developmental processes.
RESULTS
H3.3 Depletion Results in Globally Reduced Chromatin
Dynamics at Promoters and Reduced H3K27me3
Enrichment at Promoters of Developmentally
Regulated Genes
In mammals, histone H3.3 is encoded by two different genes
(h3f3a and h3f3b) whose transcription results in identical protein
products (H3.3A and H3.3B) (Wellman et al., 1987). We used a
designed zinc finger nuclease (ZFN) to knock out both alleles
of h3f3b, along with two independent short hairpin RNAs
(shRNA) targeted against the h3f3a transcript, to generate two
H3.3-depleted ESC lines (H3.3 KD1 and H3.3 KD2; Figures 1A,
1B, S1B, and S1C). As a control, we generated an H3.3B-HA
epitope-tagged ESC line carrying a nontargeting shRNA
sequence.
As studies from Mito et al. (2007) have linked regions of high
nucleosome turnover in Drosophila to H3.3 deposition and as
our own previous studies demonstrated enrichment of H3.3 at
bivalent loci in ESCs as defined by Mikkelsen et al. (2007) (see
also Goldberg et al., 2010), we first tested whether bivalent lociFigure 1. H3.3 Depletion Results in Global Loss of Nucleosome
Developmentally Regulated Genes
(A) H3.3 transcript levels in control and H3.3-depleted ESCs (n = 3 ± SD).
(B) Immunoblot of H3.3 and total H3 in nuclear extracts from control and H3.3-d
(C) H3.3 enrichment profiles at the TSS of genes classified by bivalency (Mikkels
(D) Box plots represent CATCH-IT normalized to H3gen ChIP-seq at promoters in
25th and 75th percentiles, and the internal band is the 50th percentile (median). The
using Wilcoxon tests.
(E and F) ChIP-qPCR analyses of (E) H3K4me3 and (F) H3K27me3 at representati
bars represent SD from one experiment (n = 3). Data are representative of at lea
(G and H) Genome browser representations of H3.3, H3K4me3, H3K27me3, and
Actin (left) and Rps19 (right), and (H) two developmentally regulated bivalent gene
of reads for each data set.
(I) ChIP-seq profiles of H3K4me3 (left) and H3K27me3 (right) at the TSS of biva
mapped million per 50 bp bin.
(J) Ratio of H3K27me3 peak heights in control versus H3.3 KD1 ESCs at promoter
end site [TES] excluding promoter peaks), and intergenic (all other) peaks, defined
H3K27me3 enrichment upon H3.3 depletion.
See also Figure S1 and Table S1.were areas of active turnover in mammalian systems and
whether chromatin dynamics were altered in H3.3-depleted
ESCs. We first confirmed the presence of H3.3 at bivalent loci
in ESCs (Figure 1C). To measure nucleosome turnover, we
usedCATCH-IT (covalent attachment of tags to capture histones
and identify turnover) (Deal et al., 2010). CATCH-IT measures
nucleosome dynamics (i.e., incorporation of newly synthesized
histones) via a pulse of metabolite labeling, capture of labeled,
chromatinized H3/H4 histones, and sequencing of associated
DNA fragments. The CATCH-IT profile in control ESCs was
similar to that of H3.3 enrichment and correlated well with
gene expression (Figure S1D). Consistent with the presence of
H3.3 at bivalent loci, bivalent promoters showed nearly identical
nucleosome dynamics to promoters modified only with
H3K4me3 (Figure 1D) after normalizing for total number of non-
duplicate mapped reads and nucleosome occupancy levels (as
determined by chromatin immunoprecipitation sequencing
[ChIP-seq] using a general H3 antibody). Analysis of chromatin
dynamics in the absence of H3.3 showed reduced nucleosome
turnover at both active and bivalent promoters (Figure 1D).
To assess the chromatin landscape at promoters in ESCs, we
performed ChIP using antibodies recognizing H3K4me3 and
H3K27me3, followed by qPCR analysis (ChIP-qPCR) of selected
housekeeping and developmentally regulated genes in both
control and H3.3-depleted ESCs. As H3.3 has traditionally
been associated with actively transcribed chromatin enriched
with H3K4me3, we expected to observe a decrease in
H3K4me3 enrichment at promoters of housekeeping genes in
the absence of H3.3. Surprisingly, we observed no difference
in H3K4me3 enrichment at highly expressed housekeeping
genes such as b-actin (Actin) and ribosomal protein S19
(Rps19) in the absence of H3.3 (Figure 1E). This unexpected
finding is in agreement with our previous observation that
knockout of Hira, the chaperone responsible for genic H3.3
deposition, resulted in minimal transcriptional changes in ESCs
(Goldberg et al., 2010). Additionally, H3.3 depletion had little
effect on H3K4me3 levels at developmentally regulated bivalent
genes (Figure 1E). In contrast, our ChIP-qPCR analysis of
H3K27me3 at bivalent genes showed a clear reduction of enrich-
ment in the absence of H3.3 (Figure 1F; see Figures S1E and S1FTurnover and Reduced H3K27me3 Enrichment at Promoters of
epleted ESCs. Direct blue stain as loading control.
en et al., 2007).
control and H3.3 KD ESCs. The bottom and top of the boxes correspond to the
plot whiskers correspond to 1.53 interquartile range. p values were calculated
ve housekeeping and bivalent genes in control and H3.3-depleted ESCs. Error
st three independent ChIP experiments.
H3gen profiles in control and H3.3 KD1 ESCs for (G) two housekeeping genes,
s in ESCs, Tbx3 (left), and Lhx5 (right). Read counts normalized to total number
lent genes in control and H3.3 KD1 ESCs. Data are represented as reads per
(±2 kb from TSS), promoter-distal (50 kb from TSS to +5 kb from transcription
by distance from nearest annotated genes. x axis values > 1 indicate reduced
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Figure 2. Transcription Factors Essential for Trophectoderm Specification Are Upregulated upon H3.3 Depletion
(A and B) RNA-seq data sets were obtained from control and H3.3 KD ESC poly(A)-RNA, and FPKM were calculated for all mouse Ensembl genes. Differentially
expressed genes were identified using Cuffdiff with FDR < 0.05. FPKMs for genes (A) upregulated or (B) downregulated in both H3.3 KD1 and H3.3 KD2 (Venn
diagrams) with respect to control are represented by box plots. The bottom and top of the boxes correspond to the 25th and 75th percentiles, and the internal band
is the 50th percentile (median). The plot whiskers correspond to the 10th and 90th percentiles. p values were calculated using Wilcoxon tests.
(C) Gene ontology biological process categories for genes significantly upregulated upon H3.3 knockdown from analysis performed with DAVID software (Huang
et al., 2009).
(legend continued on next page)
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for antibody specificity). This result was reproducible over inde-
pendent experiments using bulk or clonally selected knockdown
cells and a second H3K27me3 antibody and required depletion
of both H3.3A and H3.3B (Figures S1G and S1H).
We next used ChIP-seq to determine whether H3K27me3
enrichment was reduced genome wide at developmentally regu-
lated genes in the absence of H3.3. Comparison of ChIP-seq
enrichment at housekeeping genes Actin and Rps19 (Figure 1G)
and bivalent genes Tbx3 and Lhx5 (Figure 1H) confirmed our
ChIP-qPCR observations in that, whereas H3K4me3 enrichment
was unperturbed, H3K27me3 enrichment at bivalent genes was
strikingly reduced upon H3.3 depletion. Reduced H3K27me3
enrichment cannot be attributed to reduced nucleosome occu-
pancy upon depletion of H3.3, as overall levels of H3 (H3gen)
showed little variation at either housekeeping genes or bivalent
genes (Figures 1G and 1H).
To identify all bivalent genes in ESCs, we used MACS (Zhang
et al., 2008) to call H3K4me3 and H3K27me3 peaks from our
control data sets and then grouped genes according to enrich-
ment at the promoter region (±2 kb of the transcription start
site [TSS]). We identified 15,670 genes in control ESCs contain-
ing promoters enriched with H3K4me3 only and 2,938 genes
enriched with both H3K4me3 and H3K27me3 (Table S1). The
vast majority of genes enriched with H3K27me3 were also en-
riched with H3K4me3 (23 genes were classified as enriched
with H3K27me3 only). H3K4me3 enrichment at promoters of
bivalent genes was nearly identical in control and H3.3 KD1
ESCs (Figure 1I, left). In agreement with our ChIP-qPCR data,
genome-wide analysis of promoters of these genes showed a
decrease in H3K27me3 enrichment upon H3.3 depletion (Fig-
ure 1I, right, p = 2.2 3 1016) with no loss of nucleosome occu-
pancy (Figure S1I). Decreased H3K27me3 enrichment in H3.3
KD1 ESCs resulted in a reduction of bivalent domains, with
only 1,588 such classified genes upon H3.3 depletion (Table S1).
We further studied the effect of H3.3 knockdown by analyzing
H3K27me3 in control and H3.3 KD1 ESCs. Among the 3,125
H3K27me3 promoter peaks identified in both control and H3.3
KD1 ESCs, 2,081 (67%) showed greater than 1.5-fold reduc-
tion of H3K27me3 enrichment upon H3.3 depletion (Figure 1J).
By comparison, promoter-distal and intergenic regions enriched
for H3K27me3 (see Figure 1 legend; 3,583 and 5,534 regions,
respectively) showed little perturbation upon depletion of H3.3
(Figures 1J and S1J). Differences in global H3K27me3 levels
could not be distinguished by immunoblotting (Figure S1K),
perhaps because promoter-proximal peaks account for only
25% of total H3K27me3 peaks identified. Additionally, we
observed increased enrichment of H3K27me3 at short tandem
(AT)n repeat regions in H3.3 KD1 ESCs, along with a small
increase of enrichment on the Y chromosome (Figure S1L).
Gene ontology analysis using the Genomic Regions Enrichment(D) RT-qPCR of pluripotency and selected lineage marker genes in control and H
control normalized to 1. Error bars represent SD for an experiment performed in
(E) Immunoblot of control ESCs and H3.3 KD1 ESCs exogenously expressing C-
(F) RT-qPCR of trophectoderm-specific transcription factors in control ESCs an
resented as mean expression relative to Gapdh ± SD (n = 3).
(G–I) Box plots representing ChIP-seq read counts at promoters of genes upregu
H3K27me3, and (I) H3K27ac in both control and H3.3 KD1 ESCs. Plots as in (A)
See also Figure S2 and Table S2.of Annotation Tool (GREAT) (McLean et al., 2010) showed that
genes displaying at least a 1.5-fold reduction of H3K27me3 at
their promoters upon H3.3 depletion are enriched for neural
tube mesenchyme and ear development and are associated
with structural and neuronal ear defects in mouse knockout
studies (Figure S1M), suggesting that, in vivo, this early lineage
may be particularly susceptible to disruptions in chromatin
architecture in the absence of H3.3. In fact, a recent study has
shown that a mutation preventing H3.3 incorporation into chro-
matin in zebrafish results in craniofacial abnormalities (Cox
et al., 2012).
Depletion of H3.3 Allows Upregulation of Transcription
Factors Essential for the Trophectoderm Lineage in
Mouse ESCs
To determine whether H3.3-dependent reduction of H3K27me3
enrichment at bivalent genes resulted in their global transcrip-
tional upregulation, we performed gene expression profiling by
RNA sequencing (RNA-seq) for both control and H3.3-depleted
ESCs. Analysis of these data revealed modest changes in gene
expression upon H3.3 depletion, with only 84 genes upregulated
(Figure 2A) and 9 genes downregulated (Figure 2B) in both H3.3-
depleted cell lines, as compared to control shRNA-treated ESCs
(p < 0.05 with multiple testing correction, Table S2). After treat-
ment with either shRNA, h3f3a was one of the most downregu-
lated genes, confirming efficiency of knockdown.
Consistent with minimal transcriptional changes, we found
that H3.3 is not required for maintenance of the mouse ESC
state. H3.3-depleted ESCs showed colony morphology identical
to control ESCs and normal proliferation under growth condi-
tions promoting self-renewal (Figures S2A and S2B). In addition,
protein levels of key pluripotency transcription factors Oct4 and
Sox2 were unaltered (Figure S2C). After more than 1 month in
culture, H3.3-depleted ESCs maintained a normal diploid karyo-
type (data not shown), suggesting that H3.3 is not required for
proper chromosome segregation in this cell type, despite its pro-
posed role as an S phase place marker for the centromeric
histone variant CENP-A (Dunleavy et al., 2011) and defective
chromosome segregation observed in h3f3b/ mice (Bush
et al., 2013).
Gene ontology analysis of upregulated transcripts byRNA-seq
revealed themost significant overlapwith genes encoding glyco-
sylated proteins (p < 104) and genes expressed in the placenta
(p < 104) (Figure 2C). This is intriguing given that ESCs are
typically restricted from differentiation into extraembryonic
trophectoderm that gives rise to the placenta (Rossant, 2008).
Upregulated transcripts were validated by RT-qPCR (Figures
2D and S2D) and included transcription factors essential for tro-
phectoderm establishment (e.g., Cdx2, Hand1, Dlx3, and Ets1)
and multiple imprinted genes (e.g., Meg3, Peg10, and Igf2),3.3 KD ESCs. Data are represented as mean expression relative to Gapdh with
biological triplicate and technical duplicate, ***p < 0.001.
terminally Flag-HA tagged H3.2 or H3.3.
d H3.3 KD1 ESCs exogenously expressing either H3.2 or H3.3. Data are rep-
lated by RNA-seq (RNA-seq up) and bivalent promoters for (G) H3K4me3, (H)
and (B), except plot whiskers correspond to 1.53 interquartile range.
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many of which function in extraembryonic tissues (Hudson et al.,
2010).We observed no upregulation of endoderm (Gata4, Gata6,
and Sox17), mesoderm (Nodal and Brachury), or ectoderm (Nes-
tin and Fgf5) lineage markers (Figure 2D). Upregulation of Cdx2
and Hand1 in the absence of a decrease in expression of plurip-
otency factors was confirmed using an independent clonal
knockout of h3f3b (Figure S2E) and required loss of both
H3.3A and H3.3B (Figure S2F). Importantly, exogenous ex-
pression of H3.3, but not H3.2, was able to partially reduce
trophectoderm-specific transcription factor expression in H3.3
KD1 ESCs (Figures 2E and 2F).
To understand the susceptibility of this small subset of genes
to loss of H3.3, we examined the chromatin landscape of these
genes both in the presence and upon depletion of H3.3. For all
84 transcripts upregulated upon H3.3 depletion, we observe a
gain of H3K4me3 (p = 0.006) and a loss of H3K27me3 (p =
0.01) enrichment at the promoter (Figures 2G, 2H, S2G, and
S2H). Recent studies have shown that global loss of
H3K27me3 results in concomitant increase in acetylation of H3
on lysine 27 (H3K27ac), with loci-specific analyses suggesting
that these modifications are mutually exclusive (Lau and
Cheung, 2011; Pasini et al., 2010; Reynolds et al., 2012; Tie
et al., 2009). We therefore profiled H3K27ac in our control and
H3.3-depleted ESCs (Figures 2I and S2I). Analysis of the pro-
moters of genes upregulated upon H3.3 depletion revealed an
increase in H3K27ac (p = 0.0001). Likewise, we observed a sig-
nificant H3K27ac increase upon depletion of H3.3 at all bivalent
promoters (p = 2.23 1016). Interestingly, H3K27ac levels in pro-
moters of genes upregulated upon H3.3 depletion as compared
to all bivalent promoters were significantly elevated even in the
control sample (p = 1.4 3 105), whereas H3K27me3 levels
were decreased (p = 2.2 3 1016). These results suggest that
the balance of H3K27ac versus H3K27me3 is perturbed upon
depletion of H3.3, possibly contributing to aberrant gene
expression.
H3.3 Depletion Alters the Differentiation Potential
of ESCs
Our RNA-seq results suggest that H3.3-depleted ESCs may be
able to access the extraembryonic trophectoderm lineage. To
assess the developmental potential of H3.3-depleted ESCs,
we injected cells subcutaneously into immunodeficient mice
and allowed them to give rise to teratomas, tumor-like forma-
tions containing tissues from all three embryonic germ layers.
This assay can identify mutations in ESCs that allow contribution
to trophectoderm (Koh et al., 2011; Lu et al., 2008).
Histological analysis showed that H3.3-depleted ESCs suc-
cessfully differentiated into the three embryonic germ layers,
with contribution to endoderm, ectoderm, and mesoderm
similar to teratomas from control ESCs (Figures 3A and S3A).
In addition, multiple hemorrhagic placental-like structures
were observed in all teratomas derived from H3.3-depleted
ESCs (Figures 3A, S3A, and S3B), whereas only one small
area was observed in one teratoma derived from control
ESCs (control, n = 12; H3.3 KD1, n = 12; H3.3 KD2, n = 3).
These foci contained many giant cells with large nuclei and
multinucleated cells (indicated by arrows in Figure 3A, right),
which is indicative of extraembryonic trophoblast giant cells.112 Cell 155, 107–120, September 26, 2013 ª2013 Elsevier Inc.Additionally, these foci stained positively for Troma-I, an anti-
body that detects keratin 8 expressed by trophectoderm
(Figure S3B). As keratin 8 expression is not exclusive to tro-
phectoderm (see epithelial endoderm staining present in H3.3
KD1 and H3.3 KD2 teratomas in Figure S3B that was also
present in control teratomas), we isolated RNA from control
and H3.3 KD1 teratomas (Figure 3B). RT-qPCR showed upre-
gulation of Cdx2 and Hand1, two transcription factors essential
for formation of trophoblast, in teratomas derived from H3.3-
depleted ESCs. We also observed upregulation of Dlx3, a
homeobox transcription factor whose deletion results in fetal
death due to abnormal placental development (Morasso
et al., 1999), and placental cadherin (Cdh3). Together, these
histological and expression analyses demonstrate that H3.3-
depleted ESCs can differentiate toward the typically restricted
trophectoderm lineage.
In H3.3-depleted ESCs, global reduction of H3K27me3 at
promoters does not result in global upregulation of develop-
mentally poised genes (see the modest changes in gene
expression shown in Figures 2A and 2B). We therefore consid-
ered that H3.3-dependent reduction of H3K27me3 enrichment
at developmentally regulated promoters (Figures 1E, S3C,
and S3D) might result in gene misregulation upon differentia-
tion rather than deregulation in the pluripotent state. To test
this, control and H3.3-depleted ESCs were subject to
embryoid body formation by cell aggregation and withdrawal
of leukemic inhibitory factor (LIF) from the culture medium.
As expected, both Cdx2 and Hand1 were upregulated in
H3.3-depleted cells compared to control cells over the course
of the differentiation experiment (Figure 3C). In addition, we
observed upregulation of Gata4 and Gata6, primitive endo-
derm markers (Figure 3D), as well as Brachury and Fgf8, meso-
derm markers (Figure 3E), at distinct time points after LIF
withdrawal. We observed no delay in the downregulation of
pluripotency factors (data not shown) and no upregulation of
the ectoderm markers Nestin and Pax6 in H3.3-depleted cells
(Figure S3E).
To assess the effect of H3.3 depletion on gene expression
in a more differentiated cell type, we injected H3.3 null ESCs
into blastocysts and isolated mouse embryonic fibroblasts
(MEFs) at greater than 90% purity from the resulting chimeras
(Figures S3F and S3G). RNA-seq showed 1,287 misregulated
genes, with nearly even distribution of up- (635) and down-
regulated (642) genes. Analysis of all genes differentially
expressed (DE) in MEFs showed that 24% were bivalent in
ESCs, a 2-fold enrichment over total (12% of all genes were
defined as bivalent in ESC) (Figure 3F; p < 2.2 3 1016).
When DE genes in MEFs were further binned into 2-fold up-
or downregulation, fold-enrichment over total was 1.5 and
2.7, respectively. A more stringent threshold of 5-fold up- or
downregulation resulted in fold enrichment of 1.9 and 3.2,
respectively. DE genes in MEFs had H3.3 levels in ESCs that
were 20% higher than genes that showed no change in expres-
sion between control and H3.3 null cells (p < 2.2 3 1016).
Overall, our data suggest that expression of at least a subset
of bivalent genes showing reduced H3K27me3 enrichment is
perturbed upon H3.3 depletion once factors supporting self-
renewal are removed.
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Figure 3. H3.3-Depleted ESCs Show Altered Potential and Misregulation of Lineage-Specific Factors upon Differentiation
(A) Histology of teratomas from control (left) and H3.3 KD1 (right) ESCs. Sections were stained with hematoxylin and eosin (H&E). Trophoblast focus is outlined,
and representative giant trophoblast cells are indicated by arrows (right).
(B) RT-qPCR of placental markers in control and H3.3 KD1 teratomas. Data are represented as mean expression relative to Gapdh ± SD for an experiment
performed in biological and technical triplicate. *p < 0.05, **p < 0.01, and ***p < 0.001.
(C–E) RT-qPCR of indicated lineage markers in control and H3.3 KD1 ESCs subject to differentiation. Data are represented as mean expression relative to
Gapdh ± SD (n = 3) at time points indicated, normalized to control ESCs.
(F) Fold enrichment over ESC of genes defined as ESC bivalent found differentially regulated in H3.3 null MEFs. For all comparisons, p < 1 3 106.
See also Figure S3.H3.3-Dependent Chromatin Dynamics Contribute to
PRC2 Binding and Activity at Developmentally
Regulated Bivalent Promoters in ESCs
Wenext wanted to understand how loss of H3.3 deposition leads
to changes in H3K27me3 levels at developmentally regulated
promoters. We first tested whether PRC2 preferred H3.3 over
canonical H3 as a substrate. However, an in vitro histone meth-
yltransferase assay using the minimal recombinant PRC2 com-
plex (Eed, Ezh2, Suz12, and RbAp48) showed similar activity
toward both H3.2- and H3.3-containing recombinant mononu-
cleosomes (Figures S4A–S4C). Loss of H3K27me3 at promoters
could not be attributed to globally reduced levels of PRC2 in
H3.3-depleted ESCs (Figures S4D and S4E). Additionally, we
did not observe expression changes in UTX and Jmjd3, the
H3K27me3 demethylases (Figure S4F), nor were Jmjd3 or UTX
enrichment at target loci perturbed in the absence of H3.3 (Fig-
ures S4G–S4I).
We finally tested whether H3.3 depletion reduced PRC2
enrichment at the promoters of developmentally regulated genes
in ESCs. Similar to what we observed with H3K27me3 enrich-
ment, enrichment of PRC2 complex members Suz12 and Jarid2at promoter-distal and intergenic H3K27me3 peaks showed
minimal differences in the absence of H3.3 (Figure S4J). How-
ever, H3.3 knockdown reduced PRC2 enrichment at bivalent
promoters (Figure 4A), suggesting that reduction of H3K27me3
is due at least in part to decreased PRC2 enrichment at its target
promoters. H3.3 levels at developmental loci in Suz12/ ESCs
were not reduced, suggesting that H3.3 incorporation is up-
stream of PRC2 recruitment (Figure 4B).
Because H3.3 depletion reduced H3K27me3 and PRC2 levels
at bivalent promoters, we next tested whether methylation of
Lys27 on H3.3 was required to prevent upregulation of trophec-
toderm transcription factors in ESCs (see Figure 2F). We intro-
duced point mutations of H3.3 at Lys27 (H3.3K27A and
H3.3K27R) into H3.3 KD1 ESCs (Figure 4C). Surprisingly, we
found that expression of either H3.3K27A or H3.3K27R in
H3.3-depleted ESCs was sufficient to prevent upregulation of
Cdx2 and Hand1, suggesting that methylation of H3.3 itself is
not required to rescue expression phenotypes in ESCs. This un-
expected result suggests that, instead of acting as the primary
substrate for PRC2, H3.3 facilitates the proper chromatin envi-
ronment for PRC2 occupancy at its target regions and/or forCell 155, 107–120, September 26, 2013 ª2013 Elsevier Inc. 113
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Figure 4. H3.3 Contributes to PRC2 Binding at Bivalent Promoters
(A) ChIP-qPCR of Suz12 (top) and Jarid2 (bottom) at representative house-
keeping and bivalent genes in control and H3.3-depleted ESCs. Error bars
represent SD (n = 3). Data were confirmed by multiple biological replicates.
(B) H3.3 enrichment profile at the TSS of bivalent genes in wild-type
and Suz12/ ESCs. Data are represented as reads per mapped million per
50 bp bin.
(C) RT-qPCR of trophectoderm-specific transcription factors in control ESCs
and H3.3 KD1 ESCs exogenously expressing H3.2, H3.3, or H3.3 mutated at
K27. Data are represented as mean expression relative to Gapdh ± SD (n = 3).
Data from control and H3.2/H3.3 addback are also shown in Figure 2F.
See also Figure S4.PRC2 activity toward H3, regardless of isoform (i.e., H3.1/2
or H3.3).
Hira-Dependent Deposition of H3.3 Facilitates
Establishment of the Bivalent Chromatin Landscape
at Developmentally Regulated Genes in ESCs
The histone chaperone Hira is associated with replication-inde-
pendent deposition of H3.3 into chromatin (Tagami et al.,
2004). Recent studies have refined our understanding of H3.3
incorporation into chromatin by demonstrating that Hira is
responsible for most, if not all, H3.3 deposition in genic regions,
including deposition within the promoters of bivalent genes (Fig-
ure S5A), and an alternate chaperone system, Atrx/Daxx, facili-
tates H3.3 deposition atmany nongenic repeat regions (Filipescu
et al., 2013).
To determine whether the chromatin landscape at develop-
mentally regulated genes was dependent upon either Hira- or
Atrx/Daxx-dependent H3.3 deposition, we performed ChIP-
qPCR experiments in both Hira/ and Daxx-depleted ESCs
(Figures S5B and S5C). Loss of Hira had no effect on
H3K4me3 levels at housekeeping genes Actin and Rps19 (Fig-
ure 5A), in agreement with our previous observation that Hira-
dependent H3.3 deposition is not required for maintenance of
gene expression in pluripotent cells (Goldberg et al., 2010). Simi-
larly, no consistent pattern of change in H3K4me3 enrichment
was obvious at developmentally regulated genes in Hira/
ESCs (Figure 5A); while we observe an 2-fold increase in
H3K4me3 enrichment at the Tbx3 promoter, RT-qPCR shows
Tbx3 upregulation inHira/ESCs (data not shown). Daxx deple-114 Cell 155, 107–120, September 26, 2013 ª2013 Elsevier Inc.tion had no effect on H3K4me3 enrichment at either house-
keeping or developmentally regulated genes (Figure 5B), which
is unsurprising given its role in H3.3 deposition at repeat ele-
ments. Finally, we performed ChIP-qPCR to analyze
H3K27me3 enrichment at bivalent promoters in the absence of
either Hira or Daxx. In support of our observations in H3.3-
depleted ESCs, we observe reduced H3K27me3 enrichment at
bivalent promoters in Hira/ ESCs (Figure 5C), whereas Daxx
knockdown did not affect H3K27me3 enrichment (Figure 5D).
As observed in H3.3-depleted ESCs, Hira/ ESCs also showed
reduced enrichment of the PRC2 components Suz12 and Jarid2
at bivalent promoters (Figures 5E and 5F) not coupled to
changes in protein expression level (Figure S5D); although
perturbation of Suz12 at promoter-distal or intergenic
H3K27me3 peaks was minimal, we did observe reduced enrich-
ment of the low levels of Jarid2 at these regions (Figure S5E).
Overall, these data are in agreement with Hira-dependent depo-
sition of H3.3 at the promoters of developmentally regulated
genes (Figures S5F–S5H).
In accordance with the loss of newly incorporated histone at
promoters in the absence of H3.3 (Figure 1D) and the require-
ment of Hira for H3.3 deposition at promoters (Figure S5A),
Hira/ ESCs show reduced nucleosome turnover at both active
(p < 2.2 3 1016) and bivalent loci (p = 8.1 3 1012) (Figure 5G).
The lack of change in gene expression or H3K4me3 enrichment
observed in the absence of H3.3 or Hira, conditions that reduce
nucleosome turnover, supports that expression of active genes
and maintenance of their associated chromatin states do not
require incorporation of newly synthesized histones. In contrast,
Hira-dependent H3.3 deposition associated with nucleosome
turnover facilitates H3K27me3 enrichment at bivalent loci.
To test whether Hira deletion and H3.3 depletion have the
same effect on gene expression, we subjected wild-type and
Hira/ ESCs to in vitro differentiation as described above. In
agreement (Figures 2D and 3C), the trophoblast-specific tran-
scription factors Cdx2 and Hand1 are upregulated both in the
pluripotent state as well as all time points of differentiation in
the absence of Hira (Figure 5H).
Hira Colocalizes with Promoter-Proximal RNA
Polymerase II and the PRC2 Complex at the Promoters
of Developmentally Regulated Genes in ESCs in an
H3.3-Dependent Manner
Because Hira/ ESCs recapitulated the loss of H3K27me3 and
PRC2 at bivalent promoters, we next sought to determine
whether Hira localized to these regions. We generated an ESC
line stably expressing Hira C-terminally tagged with the 3xFlag
epitope (Figure S6A; Hira3xFlag) and performed ChIP-seq using
a Flag-specific M2 antibody. Chromosome-wide analysis
showed that Hira and H3.3 display similar enrichment profiles
(Pearson correlation coefficient of 0.78, p < 2.2 3 1016), with
enrichment observed at genic regions (Figure 6A). We next
aligned our ChIP-seq data to the TSS of genes binned by expres-
sion level. In agreement with Hira’s role as a chaperone for genic
H3.3 deposition and H3.3’s association with transcription, as
well as a recent Hira ChIP-seq data set (Pchelintsev et al.,
2013), enrichment of Hira and H3.3 were both associated with
gene expression levels (Figure S6B).
C D
0
0.5
1.0
1.5
2.0
2.5
%
 in
pu
t
H3K27me3
Control
Daxx shRNA-1
Daxx shRNA-2
Control
Hira-/-
Cd
x2
H
an
d1
As
cl
2
G
at
a6
So
x1
7
N
es
tin
Ac
tin
R
ps
19
Fg
f5
Ev
x1
Lh
x5 Lr
at
Tb
x3
house-
keeping
bivalent
Cd
x2
H
an
d1
As
cl
2
G
at
a6
So
x1
7
N
es
tin
Ac
tin
R
ps
19
Fg
f5
Ev
x1
Lh
x5 Lr
at
Tb
x3
house-
keeping
bivalent
0
1
2
3
4
5
6
7
%
 in
pu
t
H3K27me3
A B
0
10
20
30
40
50
60
70
80
%
 in
pu
t
H3K4me3
Control
p<2.2x10-16
p=8.1x10-12
Daxx shRNA-1
Daxx shRNA-2
Control
Hira-/-
Cd
x2
H
an
d1
As
cl
2
G
at
a6
So
x1
7
N
es
tin
Ac
tin
R
ps
19
Fg
f5
Ev
x1
Lh
x5 Lr
at
Tb
x3
house-
keeping
bivalent
Cd
x2
H
an
d1
As
cl
2
G
at
a6
So
x1
7
N
es
tin
Ac
tin
R
ps
19
Fg
f5
Ev
x1
Lh
x5 Lr
at
Tb
x3
house-
keeping
bivalent
0
10
20
30
40
50
60
70
%
 in
pu
t
H3K4me3
CA
TC
H-
IT
/H
3g
en
(no
rm
ali
ze
d C
hIP
-se
q r
ea
ds
)
0
1
2
3
H3K4me3 bivalent
W
T
H
ira
-/- W
T
H
ira
-/-
G
H
0
5
10
15
20
25
ESC
–LIF (days)
2 4 6 8
Cdx2
0
40
80
120
160
200
R
el
at
iv
e 
m
R
N
A 
le
ve
ls
Hand1
Control
Hira-/-
E F
house-
keeping
bivalent
Ac
tin
R
ps
19
Cd
x2
H
an
d1
As
cl
2
G
at
a6
So
x1
7
N
es
tin
Fg
f5
Ev
x1
Tb
x3
Lh
x5 Lr
at
house-
keeping
bivalent
Ac
tin
R
ps
19
Cd
x2
H
an
d1
As
cl
2
G
at
a6
So
x1
7
N
es
tin
Fg
f5
Ev
x1
Tb
x3
Lh
x5 Lr
at
0
1
2
3
4
5
%
 in
pu
t
Jarid2
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
%
 in
pu
t
Suz12Control
Hira-/-
Control
Hira-/-
Figure 5. Maintenance of H3K27me3 Levels at Bivalent Promoters Requires Hira-Dependent H3.3 Deposition
(A–D) ChIP-qPCR of H3K4me3 (A and B) and H3K27me3 (C and D) at representative housekeeping and bivalent genes in control andHira/ ESCs (A and C) and
control and Daxx-depleted ESCs (B and D).
(E and F) ChIP-qPCR of (E) Suz12 and (F) Jarid2 at representative housekeeping and bivalent genes in control and Hira/ ESCs. For (A)–(F), error bars represent
SD (n = 3) with data confirmed by three biological replicates.
(G) Box plots represent CATCH-IT normalized to H3gen ChIP-seq at promoters in control and Hira/ ESCs. The bottom and top of the boxes correspond to the
25th and 75th percentiles, and the internal band is the 50th percentile (median). The plot whiskers correspond to 1.53 interquartile range. p values were calculated
using Wilcoxon tests.
(H) RT-qPCR of trophectoderm markers in control and Hira/ ESCs subject to differentiation. Data are represented as mean expression relative to Gapdh ± SD
(n = 3) at the time points indicated, normalized to control ESCs.
See also Figure S5.We next assessed the enrichment of various chromatin-
related factors at genes classified by their histone posttransla-
tional modification status (Figure 6B) using published data sets
for PRC2 (Peng et al., 2009) and RNAPII (Brookes et al., 2012).Promoters marked by H3K4me3 only were also associated
with Hira and H3.3, but not PRC2 (H3K27me3, Ezh2, Suz12,
and Jarid2). H3K4me3-only promoters were enriched with
RNAPII S5p, which is consistent with promoter-proximal pausingCell 155, 107–120, September 26, 2013 ª2013 Elsevier Inc. 115
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Figure 6. Hira Colocalizes with Promoter-Proximal RNAPII and PRC2 at Bivalent Promoters in an H3.3-Dependent Manner
(A) Genome browser representation of input, H3.3, and Hira profiles for chromosome 11. Read counts are normalized to total number of reads obtained for each
data set.
(B) ChIP-seq density heatmaps for RefSeq genes classified as H3K4me3 only (n = 15,670), bivalent (n = 2,938), or H3K27me3 only (n = 23). Plots show ± 5 kb
centered on the TSS. H3K4me3-only genes are rank ordered by H3K4me3 enrichment, and bivalent and H3K27me3 only genes are rank ordered by H3K27me3
enrichment, based on FPKM for each ChIP-seq data set. Data are represented as reads per mapped million per 50 bp bin. Color intensity represents tag counts,
which are standardized across gene groupings for each ChIP-seq data set.
(C) Immunoblotting of Hira immunoprecipitated from wild-type or H3.3 null nuclear extracts showing coimmunoprecipitation with Ubinuclein and H3.3 (asterisk
indicates nonspecific band) (5% input) and H3.3-dependent coimmunoprecipitation with RNAPII S5p, Ezh2, Suz12, and Jarid2 (0.5% input).
(D) Hira enrichment profile at the TSS of genes classified by chromatin modification state in wild-type (solid lines) and H3.3 KO2 (dashed lines) ESCs. Data are
represented as reads per mapped million per 50 bp bin.
(E) Model of H3.3 in modulation of PRC2 recruitment and activity in ESC. Recruitment of Hira and H3.3 to PRC2 targets is codependent and is upstream of PRC2
recruitment. Either Hira or H3.3 directly or the high frequency of free DNA afforded by their presence allows for optimal PRC2 recruitment and activity at target loci.
See also Figure S6.of active genes, as well as RNAPII S2p (Figure 6B). As expected,
promoters with both H3K4me3 and H3K27me3 were enriched
with PRC2 and RNAPII S5p, albeit at lower levels than observed
in genes marked by H3K4me3 only. Consistent with our initial
observation that bivalent promoters are enriched with H3.3 (Fig-
ure 1C), we observed similar patterns, albeit lower levels, of Hira
enrichment at this class of genes (Figures 6B and S6C).
Together, these data support the presence of Hira-dependent
H3.3 deposition at both active genes and targets of PRC2 regu-
lation in ESCs.116 Cell 155, 107–120, September 26, 2013 ª2013 Elsevier Inc.We next wanted to determine whether Hira physically associ-
ated with PRC2. Using nuclear extracts prepared from both
wild-type and Hira3xFlag ESCs, we found that Hira coimmuno-
precipitated its known complex member Ubinuclein and its
histone substrate H3.3 (Figures 6C and S6D). In support of our
observed colocalization of Hira and RNAPII and published
studies demonstrating their association (Ray-Gallet et al.,
2011), we found that Hira coimmunoprecipitated both pro-
moter-proximal RNAPII S5p and elongating RNAPII S2p (Figures
6C and S6D). In addition, Hira coimmunoprecipitated PRC2
complex members Ezh2, Suz12, and Jarid2 (Figures 6C and
S6D), but not Atrx (Figure 6C), demonstrating specificity of the
interaction.
To determine whether Hira-PRC2 interaction required H3.3,
we used nuclear extracts from H3.3 null ESCs to immunoprecip-
itate Hira-associated factors. Although the Hira-Ubinuclein inter-
action was maintained in the absence of H3.3, association with
both RNAPII and PRC2 was lost (Figure 6C). In agreement with
loss of association with interacting factors, we found that Hira
was not enriched at its target promoters in the absence of
H3.3 (Figure 6D). Overall, our data suggest that, whereas the
nuclear Hira complex is maintained in the absence of H3.3,
Hira andH3.3 localization to chromatin are codependent and up-
stream of PRC2 in their recruitment to bivalent promoters
(Figure 6E).
DISCUSSION
A growing literature demonstrates that embryonic stem cells
display an open chromatin state (Gaspar-Maia et al., 2011).
One signature of the pluripotent state is the presence of bivalent
domains within the promoters of developmentally regulated
genes, marked by the presence of both H3K4me3 and
H3K27me3 (Bernstein et al., 2006); most of these genes are ex-
pressed at marginally detectable to low levels in ESCs (mean
fragments per kilobase of exons per million mapped fragments
[FPKM] in our data set of 3). The bivalent chromatin landscape
is thought to contribute to the plasticity of ESCs, facilitating their
ability to rapidly initiate changes in gene expression programs
upon receipt of differentiation stimuli. Our data demonstrate
the importance of the histone variant H3.3 at bivalent promoters
and suggest that chromatin dynamics may play a key role in
maintaining this chromatin landscape.
Given its close association with active transcription, it is sur-
prising that an absolute requirement for H3.3 in the maintenance
or activation of gene expression profiles has not been identified
(Cui et al., 2006). In our study, ESCs lacking H3.3 are functionally
pluripotent, as they maintain the ability to self-renew and
contribute to all three germ layers. Others have found that
Drosophila embryos are able to develop to adulthood in the
absence of H3.3, challenging the importance of this variant for
active transcription (Ho¨dl and Basler, 2009; Sakai et al., 2009).
Additionally, our work has shown that the absence of H3.3 depo-
sition does not affect the chromatin landscape of actively tran-
scribed regions (e.g., H3K4me3 and H3K36me3). We therefore
conclude that, although H3.3 is found to be colocalized with
these activation-associated modifications, the enzymes respon-
sible for their installation show no preference toward either
canonical H3.1/2 or the variant H3.3 as a substrate (Loyola
et al., 2006) and no dependence upon H3.3 for their recruitment
or activity.
Despite the association of H3K27me3 with gene repression,
reduction of this histone posttranslational modification at biva-
lent developmentally regulated promoters upon H3.3 depletion
does not correlate with global upregulation of gene expression
under conditions promoting self-renewal. H3.3 depletion does
lead to upregulation of a small number of developmentally regu-
lated genes, in particular a number essential for establishment ofthe extraembryonic trophectoderm lineage. Placental-like foci
identified in teratomas derived from H3.3 KD ESCs constitute a
small percentage (<5%) of the resulting tumors, leading us to
conclude that only a subset of H3.3-depleted ESCs express
trophectoderm markers at sufficient levels to drive this lineage
formation and that H3.3-depleted ESCs do not, in general, repre-
sent a more totipotent cell state.
The expression data presented herein are somewhat in
contrast to observations of ESCs lacking PRC2 components
(Surface et al., 2010). While able to maintain the pluripotency
transcription program, these cells exhibit low-level derepression
of lineage-specificmarkers when cultured under conditions sup-
porting self-renewal. When subject to differentiation in vitro, they
fail to fully activate lineage-specific genes and maintain aberrant
expression of pluripotency markers. The discrepancy between
PRC2 null versus H3.3-depleted ESCs could result from incom-
plete abrogation of PRC2 activity on chromatin upon H3.3 deple-
tion; compared to H3.3-depleted ESCs, PRC2 null cells contain
drastically reduced global and local levels of H3K27me3. Alter-
natively, these discrepancies may arise from a function of H3.3
unrelated to Hira-dependent deposition into chromatin or
perhaps a function of PRC2 that is not abrogated by the loss
of H3.3 and is responsible for the PRC2 null phenotype.
In our current study, ontology analysis of the bivalent pro-
moters most affected by H3.3 depletion predicts that H3.3 may
play a critical role in neural tube mesenchyme. Indeed, zebrafish
expressing a mutant of H3.3 preventing chromatin incorporation
exhibit craniofacial skeletal defects (Cox et al., 2012). Several
additional studies suggest that H3.3 may play an essential role
in development. Hypomorphic h3f3a gene trap mice display par-
tial neonatal lethality, stunted growth, neuromuscular deficits,
and male subfertility (Couldrey et al., 1999). Deletion of Hira in
mice (Roberts et al., 2002) and depletion of H3.3 or Hira in
Xenopus laevis (Szenker et al., 2012) result in pleiotropic gastru-
lation defects and embryonic lethality, due in part to an inability
to maintain nucleosome occupancy in the absence of H3.3
(Ray-Gallet et al., 2011). We do not detect decreased nucleo-
some occupancy in H3.3-depleted ESCs. However, ESCs spend
70% of their cell cycle in S phase with access to abundant
levels of canonical H3; perhaps maintenance of nucleosome
occupancy in the absence of H3.3 would play a greater func-
tional role upon exit frompluripotency and especially upon termi-
nal differentiation.
Although we did not detect decreased nucleosome
occupancy, we did observe altered chromatin dynamics in
H3.3-depleted ESCs. As rescue of gene misregulation due to
depletion of H3.3 did not require Lys27, we hypothesize that
PRC2 can utilize either H3.3 or canonical H3 as a substrate but
that H3.3might provide a dynamic chromatin environment bene-
ficial to PRC2 localization and/or activity at the promoters of
developmentally regulated genes. Our CATCH-IT data reveal
lower levels of nucleosome turnover upon depletion of H3.3 at
both active and bivalent genes; it remains unclear why the chro-
matin landscape and transcriptional output of active loci remain
unaffected, whereas the chromatin landscape established by
PRC2 is compromised.
Interestingly, Jarid2 is able to bind free DNAwith a bias toward
GC-rich regions (Li et al., 2010), facilitating PRC2 recruitment toCell 155, 107–120, September 26, 2013 ª2013 Elsevier Inc. 117
target loci in ESCs (Margueron and Reinberg, 2011). Promoters
of developmentally regulated genes tend to beCpG-rich regions,
typically depleted of nucleosomes and enriched for H3.3. We
hypothesize that the dynamic environment associated with
H3.3 incorporation results in these regions existing in nucleo-
some-free states at higher frequency than other regions, facili-
tating Jarid2’s role in recruitment of PRC2 to CpG-rich bivalent
promoters. Intriguingly, Jarid2 is highly expressed in ESCs under
control of the pluripotency transcription machinery and is down-
regulated upon differentiation. In addition, our analysis in MEFs
demonstrates enrichment of H3.3 at both H3K4me3 and bivalent
promoters, but not at the thousand promoters modified by
H3K27me3 only (data not shown). We therefore propose that
the requirement for H3.3 and Jarid2 to fine-tune PRC2 activity
at bivalent promoters might be unique to the pluripotent state,
with alternate PRC2 recruitmentmechanisms taking precedence
in differentiated cells. This hypothesis suggests evolutionary or
developmental divergence in PRC2 recruitment mechanisms
fromDrosophila, where H3.3 is enriched at PREs in adult somatic
cells.
We report a previously unappreciated role for H3.3, a histone
variant associated with gene activation, in establishment of the
bivalent chromatin landscape at lowly expressed developmental
genes in ESCs. Our data support the emerging notion that H3.3 is
not required for active transcription but instead may be neces-
sary for establishing a chromatin landscape allowing for proper
gene expression upon differentiation. Intriguingly, point muta-
tions of H3 and H3.3, specifically at Lys27, have recently been
discovered in pediatric glioblastomas (Schwartzentruber et al.,
2012; Wu et al., 2012). In light of the work presented herein,
this finding is particularly exciting given emerging links between
development and oncogenesis, with certain types of cancers
thought to be due to either regression to a less differentiated
state or an initial failure to establish differentiation. Future studies
will address these and other roles of this unique H3 variant in
normal development and abnormal development leading to
pathological conditions.
EXPERIMENTAL PROCEDURES
ESC Culture
ESCs (C57Bl/6J background) were cultured under standard conditions.
Mouse h3f3b ZFNs and targeting were previously described (Goldberg et al.,
2010), and H3.3A shRNA constructs were purchased from OpenBiosystems
(TRCN0000012023 and TRCN0000012027). See Extended Experimental
Procedures for more details.
ChIP and Antibodies
Native and crosslinking ChIP with 2 3 107 ESCs per experiment were
performed as previously described (Goldberg et al., 2010). All antibodies
(see Extended Experimental Procedures) were previously reported as suitable
for ChIP and immunoblotting.
ChIP-Seq
ChIP-seq libraries were prepared according to the Illumina protocol and
sequenced with either the Genome Analyzer II or HiSeq 2000. Reads were
mapped to the mouse genome (build 37, mm9) using the Bowtie alignment
software (Langmead et al., 2009). Unique reads mapped to a single best-
matching location with no more than twomismatches were kept for peak iden-
tification and profile generation. MACS (Zhang et al., 2008) was used for peak
calling in each replicated sample, and the resulting peaks were filtered by peak118 Cell 155, 107–120, September 26, 2013 ª2013 Elsevier Inc.height to reduce false positives. We computed the total number of reads in
individual promoters for comparing histone modifications in different groups
of promoters. Read depths were used to normalize peak heights and promoter
modification levels across samples.
Wiggle files, generated by extending each read 100 bp from its 30 end, were
used to generate average ChIP-seq profiles using the Cistrome analysis
pipeline (http://cistrome.dfci.harvard.edu/ap/). Numbers of reads used for
analysis: H3.3 (22 million), H3K4me3 (25 million), H3K27me3 (25 million), H3
general (100 million), H3K27ac (20 million), Hira3xFlag (13.5 million), Hira (23
million), UTX (10 million), and Jmjd3 (10 million).
RNA-Seq
RNA was isolated using QIAGEN RNeasy. Libraries were prepared according
to the Illumina TruSeq protocol and were sequenced on the HiSeq 2000.
Resulting reads (101 nt) were aligned to the mouse genome (mm9) using
TopHat (Trapnell et al., 2009). Gene expression level measured as FPKM
was determined by the maximum likelihood estimation method implemented
in the Cufflinks software package with annotated transcripts as references.
Differential expression was analyzed using the Student’s t test in the program
Cuffdiff (Trapnell et al., 2010) with p values corrected for multiple testing.
Immunoprecipitation
5 mg antibody bound to 25 ml Dynabeads was incubated with 1 mg of ESC
nuclear extract (see Extended Experimental Procedures) for 3 hr at 4C. Beads
were washed four times with 1 ml buffer (20 mMHEPES [pH 7.9], 300 mMKCl,
0.01%NP-40, 5mM2-mercaptoethanol, 0.4 mMPMSF) and eluted in 13 SDS
loading buffer.
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